Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evofem Bioscience Inc (EVFM)

Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,180
  • Shares Outstanding, K 132,530
  • Annual Sales, $ 19,360 K
  • Annual Income, $ -8,860 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta -1.41
  • Price/Sales 0.43
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings $-0.01 on 11/13/25
  • Next Earnings Date 03/23/26 [--]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0083 +4.82%
on 03/06/26
0.0094 -7.45%
on 03/10/26
-0.0003 (-3.33%)
since 02/11/26
3-Month
0.0069 +26.09%
on 01/20/26
0.0136 -36.03%
on 12/12/25
-0.0043 (-33.08%)
since 12/11/25
52-Week
0.0067 +29.85%
on 03/17/25
0.0200 -56.50%
on 10/27/25
+0.0004 (+4.82%)
since 03/11/25

Most Recent Stories

More News
Evofem Reports Fifth Consecutive Year of Net Sales Growth

— Net sales surpassed $20 million mark in FY 2025 — — Income from operations increased to $3.4 million in FY 2025 —

EVFM : 0.0087 (-2.25%)
Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women’s Health at Fierce JPM Week 2026

Pelletier’s provocative keynote at Fierce JPM 2026 explores how moving beyond legacy models can drive progress in women’s health

EVFM : 0.0087 (-2.25%)
Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store

Evofem Biosciences, Inc. (“Evofem” or the “Company”) (OTCID: EVFM) today announced the launch of the Say Vagina Store , expanding its groundbreaking Say Vagina campaign...

EVFM : 0.0087 (-2.25%)
Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE

— PHEXX ® Poised to Become First and Only  Hormone-Free Contraceptive Vaginal Gel Approved in UAE —

EVFM : 0.0087 (-2.25%)
Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update

-- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --

EVFM : 0.0087 (-2.25%)
Evofem Announces Voting Results from Special Meeting of Stockholders

-- Evofem Shareholders Did Not Approve the Merger with Aditxt --

EVFM : 0.0087 (-2.25%)
ADTX : 2.67 (-2.01%)
Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates

— First ex-U.S. Regulatory Filing for SOLSOEC ® —

EVFM : 0.0087 (-2.25%)
Evofem Biosciences Honors World Contraception Day

SAN DIEGO , Sept. 26, 2025 /PRNewswire/ -- On World Contraception Day, Evofem Biosciences, Inc. ("Evofem" or "the Company") (OTCID: EVFM) honors the millions of people worldwide who rely...

EVFM : 0.0087 (-2.25%)
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

-- 130% increase in traffic to PHEXXI.com, the website for Evofem's hormone-free prescription contraceptive PHEXXI ® (lactic acid citric acid and potassium bitartrate) --

EVFM : 0.0087 (-2.25%)
ADTX : 2.67 (-2.01%)
Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting

-- Special Meeting to be held on September 26, 2025 --

EVFM : 0.0087 (-2.25%)
ADTX : 2.67 (-2.01%)

Business Summary

Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention...

See More

Key Turning Points

3rd Resistance Point 0.0099
2nd Resistance Point 0.0096
1st Resistance Point 0.0091
Last Price 0.0087
1st Support Level 0.0083
2nd Support Level 0.0080
3rd Support Level 0.0075

See More

52-Week High 0.0200
Fibonacci 61.8% 0.0149
Fibonacci 50% 0.0133
Fibonacci 38.2% 0.0118
Last Price 0.0087
52-Week Low 0.0067

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar